SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-013920
Filing Date
2022-05-31
Accepted
2022-05-31 16:35:49
Documents
14
Period of Report
2022-05-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20220526_8k.htm   iXBRL 8-K 48357
6 logo01.jpg GRAPHIC 8713
  Complete submission text file 0001437749-22-013920.txt   205784

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20220526.xsd EX-101.SCH 3601
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20220526_def.xml EX-101.DEF 11532
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20220526_lab.xml EX-101.LAB 15414
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20220526_pre.xml EX-101.PRE 11688
8 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20220526_8k_htm.xml XML 2562
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 22983926
SIC: 2834 Pharmaceutical Preparations